A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.

A study led by NYU Langone Health researchers sheds light on how the major cancer gene BRCA2 determines which cancer cells ...

The devil is in my eyes. I am haunted inside. I didn’t kill anyone,” Yarimi said after the fatal crash, according to ...

A new study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a ...

There is something special going on inside NYU Langone’s thoracic surgery service line.  Not only does the thoracic surgery team perform more surgeries than the national average, it reports no 30- and ...

Previous skepticism turns to optimism as the first clinical trials for transplantation with genetically edited pig kidneys ...

Dr. Doris Day, a board-certified dermatologist, has barely any wrinkles at 62. She has had cosmetic treatments, but said that ...

A retrospective review reports that pregnant women with pityriasis rosea onset before 15 weeks have higher rates of ...

MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to share your story, please email [email protected] or contact ...

New York Yankee Brett Gardner, has experts warning about carbon monoxide dangers amid speculations. The teen died while on ...

Joel Embiid will undergo arthroscopic surgery on his left knee next week, the 76ers announced Wednesday afternoon. The ...

Fortune and healthcare performance improvement company Premier released their 100 Top Hospitals 2025 list on April 2, ...